Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2018
The 8th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland
Presentation Date(s):- Apr 11 - 14, 2018
- Total Presentations: 407
-
+
Opening and welcome
- Type: Opening and welcome
- Presentations: 4
- Moderators:L. Paz-Ares
- Coordinates: 4/11/2018, 13:30 - 13:45, Room B
-
+
Welcome to the Congress
13:30 - 13:35 | Presenter: M. Perol
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Introduction to ESMO
13:35 - 13:40 | Presenter: S. Peters
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Introduction to IASLC
13:40 - 13:45 | Presenter: G. Scagliotti
- Abstract
No abstract available for this presentation
-
+
2018 HHH Award Winner Introduction
13:45 - 13:45 | Presenter: S. Peters
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Young Oncologist session
- Type: Young Oncologist session
- Presentations: 6
- Moderators:R. Califano
- Coordinates: 4/12/2018, 09:00 - 10:30, Room C
-
+
How to prepare a relevant clinically-based project in lung cancer
09:45 - 10:00 | Presenter: L. Paz-Ares
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Poster Display session (Friday)
- Type: Poster Display session
- Presentations: 197
- Coordinates: 4/13/2018, 12:30 - 13:00, Hall 1
-
+
195TiP - A phase 3, randomized, double-blind study of epacadostat plus pembrolizumab vs pembrolizumab as first-line therapy for metastatic non-small cell lung cancer (mNSCLC) expressing high PD-L1 levels (ECHO-305/KEYNOTE-654)
12:50 - 12:50 | Presenter: L. Paz-Ares
- Abstract
Loading...
-
+
ESMO-IASLC Best Abstracts
- Type: Best Abstract session
- Presentations: 7
- Moderators:M. Perol
- Coordinates: 4/13/2018, 16:45 - 18:30, Room B
-
+
91O - Adjuvant chemotherapy candidates in stage I lung adenocarcinomas following complete lobectomy: What does an analysis based on recurrence risk stratification tell us?
16:45 - 17:00 | Presenter: J. Qian
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
109O - Health-related quality of life (QoL) after prophylactic cranial irradiation (PCI) vs no PCI for stage III NSCLC patients: Results from the NVALT-11/DLCRG-02 study
17:00 - 17:15 | Presenter: W. Witlox
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
233O - Time to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes
17:15 - 17:30 | Author(s): R. Hui
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Invited Discussant 91O, 109O and 233O
17:30 - 17:45 | Presenter: N. Reguart
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
128O - Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with untreated EGFRm advanced NSCLC: FLAURA post-progression outcomes
17:45 - 18:00 | Presenter: D. Planchard
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
129O - EGFR-TKIs plus local therapy demonstrated survival benefit than TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases
18:00 - 18:15 | Presenter: T. Jiang
- Abstract
Loading... -
+
Invited Discussant 128O and 129O
18:15 - 18:30 | Presenter: T. Mitsudomi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Closing remarks
- Type: Closing remarks
- Presentations: 1
